{
    "code": "10000835",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000835",
    "time": "2020-08-28 04:29:54",
    "許可證字號": "衛署菌疫輸字第000835號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "111\/04\/09",
    "發證日期": "96\/04\/09",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA01000083501",
    "中文品名": "喜瑞樂凍晶注射劑150毫克",
    "英文品名": "Xolair 150 mg powder and solvent for solution for injection",
    "適應症": "1.過敏性氣喘附加療法：\r\n喜瑞樂為附加療法用於改善已接受高劑量吸入性類固醇製劑\r\n及長效乙二型作用劑(Beta 2-agonist)治療下仍有頻繁的日間症狀\r\n或夜間覺醒且具有多次重度氣喘惡化紀錄之重度持續\r\n過敏性氣喘成人、青少年及兒童(6歲及以上)的氣喘控制。\r\n這些氣喘患者必須有經由皮膚測試或體外試驗顯示對\r\n長期空氣中過敏原呈陽性且肺功能降低(FEV1",
    "劑型": "243凍晶注射劑",
    "包裝": "150毫克(附2毫升溶劑)小瓶 100小瓶以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "OMALIZUMAB",
    "限制項目": "02輸　入",
    "申請商名稱": "0924601100  台灣諾華股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號8樓",
    "主製造廠": [
        {
            "製造廠名稱": "FCH0088000  NOVARTIS PHARMA STEIN AG",
            "製造廠廠址": "SCHAFFHAUSERSTRASSE CH-4332 STEIN, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "The Final Batch"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6132061151  裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "FFR0141100  Delpharm Dijon",
            "製造廠廠址": "6, BLD DE L&#39;EUROPE 21800 QUETIGNY FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": "注射用水製造"
        },
        {
            "製造廠名稱": "FFR0220000  NOVARTIS PHARMA S.A.S.",
            "製造廠廠址": "8, RUE DE L&#39;INDUSTRIE, F-68330 HUNINGUE, FRANCE",
            "製造廠公司地址": "",
            "製造廠國別": "FRANCE",
            "製程": "主成分(drug substance)製造廠"
        }
    ],
    "CCC號列": "30049020007 血液代用品與血漿代用品及基因重組製劑Substitutes of blood, substitutes of plasma and preparations  of gennetic recombinants",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1013001300",
            "成分名稱": "OMALIZUMAB",
            "含量描述": "",
            "含量": "150.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "000835_Xolair 150 mg powder and solvent for solution for injection_2-108-06-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000835&Seq=002&Type=10"
        },
        {
            "title": "000835_Xolair 150 mg powder and solvent for solution for injection_1-108-06-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000835&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "2229826_TW_p3_LFT_X-4-109-08-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000835&Seq=008&Type=9"
        },
        {
            "title": "Xolair powder TWI-120819-109-01-03(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000835&Seq=007&Type=9"
        },
        {
            "title": "Annex 2_Xolair powder for solution for injection-TWI-120819-108-09-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000835&Seq=006&Type=9"
        },
        {
            "title": "2229827_TW_p1_FB_X-4-109-08-27(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000835&Seq=009&Type=8"
        },
        {
            "title": "Xolair powder label_201911-109-01-03(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000835&Seq=008&Type=8"
        },
        {
            "title": "Xolair powder box_201911-109-01-03(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000835&Seq=007&Type=8"
        },
        {
            "title": "Xolair-104-09-11(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000835&Seq=006&Type=8"
        }
    ]
}